Literature DB >> 6301363

Ketoconazole inhibition of testicular secretion of testosterone and displacement of steroid hormones from serum transport proteins.

D S Grosso, T W Boyden, R W Pamenter, D G Johnson, D A Stevens, J N Galgiani.   

Abstract

In vivo perfusion of canine testes with ketoconazole inhibited the stimulation of testosterone production by human chorionic gonadotropin in a dose-dependent manner. Ketoconazole also selectively displaced steroids from serum-binding globulins. Dihydrotestosterone and estradiol binding to sex hormone-binding globulin were inhibited by ketoconazole. Cortisol binding to corticosteroid-binding globulin was unaffected. The concentrations of ketoconazole that inhibited human chorionic gonadotropin stimulation of testicular androgen production and displaced sex steroids from sex hormone-binding globulin were in the range of blood levels found in patients on higher therapeutic dosage regimens. Suppression of testicular testosterone synthesis and displacement of estrogens from sex hormone-binding globulin may decrease the androgen/estrogen ratio of the blood and contribute to the development of gynecomastia that has been reported in some ketoconazole-treated patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301363      PMCID: PMC186023          DOI: 10.1128/AAC.23.2.207

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  The measurement of sex steroid binding globulin by differential ammonium sulphate precipitation.

Authors:  S O'Connor; H W Baker; A Dulmanis; B Hudson
Journal:  J Steroid Biochem       Date:  1973-07       Impact factor: 4.292

2.  The apparent free testosterone concentration, an index of androgenicity.

Authors:  A Vermeulen; T Stoïca; L Verdonck
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

Review 3.  Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.

Authors:  R C Heel; R N Brogden; A Carmine; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

4.  Changes in physiologically free circulating estradiol and testosterone during exposure to levonorgestrel.

Authors:  P G Stumpf; R M Nakamura; D R Mishell
Journal:  J Clin Endocrinol Metab       Date:  1981-01       Impact factor: 5.958

Review 5.  The pathogenesis of gynecomastia.

Authors:  J D Wilson; J Aiman; P C MacDonald
Journal:  Adv Intern Med       Date:  1980

6.  Transport of steroid hormones: interaction of 70 drugs with testosterone-binding globulin and corticosteroid-binding globulin in human plasma.

Authors:  M M Pugeat; J F Dunn; B C Nisula
Journal:  J Clin Endocrinol Metab       Date:  1981-07       Impact factor: 5.958

7.  Testosterone secretion by the isolated canine testis after controlled infusions of HCG.

Authors:  T W Boyden; R W Pamenter; M A Silvert
Journal:  J Reprod Fertil       Date:  1980-05

8.  Metabolic clearance rate and interconversion of androgens and the influence of the free androgen fraction.

Authors:  A Vermeulen; S Andó
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

9.  Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs.

Authors:  D Borelli; J L Bran; J Fuentes; R Legendre; E Leiderman; H B Levine; A Restrepo; D A Stevens
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401

10.  Gynecomastia with ketoconazole.

Authors:  R DeFelice; D G Johnson; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

View more
  14 in total

1.  Adrenal function in paracoccidioidomycosis: a prospective study in patients before and after ketoconazole therapy.

Authors:  A Abad; I Gomez; P Velez; A Restrepo
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

Review 2.  The endocrine effects of ketoconazole.

Authors:  N Sonino
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

3.  Adrenal response to corticotropin during therapy with itraconazole.

Authors:  P Phillips; J R Graybill; R Fetchick; J F Dunn
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 4.  Treatment of systemic fungal infections: recent progress and current problems.

Authors:  T J Walsh; A Pizzo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

Review 5.  Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review.

Authors:  Harsh Patel; Victor Arruarana; Lucille Yao; Xiaojiang Cui; Edward Ray
Journal:  Endocrine       Date:  2020-02-17       Impact factor: 3.633

6.  Ketoconazole in experimental vaginal candidosis in rats.

Authors:  O S Kinsman; A E Collard; T J Savage
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

7.  Effects of long-term ketoconazole therapy on serum lipid levels.

Authors:  O Rollman; S Jameson; H Lithell
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis.

Authors:  R M Tucker; P L Williams; E G Arathoon; B E Levine; A I Hartstein; L H Hanson; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

9.  Inhibition by ketoconazole of mitogen-induced DNA synthesis and cholesterol biosynthesis in lymphocytes.

Authors:  T M Buttke; S W Chapman
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

Review 10.  Ketoconazole in the treatment of coccidioidomycosis.

Authors:  J N Galgiani
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.